FERNANDO
LÓPEZ-RÍOS MORENO
Profesor asociado de Ciencias de la Salud
Universidad CEU San Pablo
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad CEU San Pablo (16)
2018
-
Aligning digital CD8
+
scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma
Histopathology, Vol. 72, Núm. 2, pp. 270-284
2017
-
Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab
Oncotarget, Vol. 8, Núm. 21, pp. 35289-35300
2016
-
Phase II trial of target-guided personalized chemotherapy in first-line metastatic colorectal cancer
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 39, Núm. 3, pp. 236-242
-
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas
Expert Review of Molecular Diagnostics, Vol. 16, Núm. 6, pp. 707-713
2015
-
The anaplastic lymphoma kinase testing conundrum
Expert Review of Molecular Diagnostics, Vol. 15, Núm. 2, pp. 161-163
2014
-
A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond
Cancer Letters, Vol. 351, Núm. 1, pp. 30-40
-
A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 37, Núm. 2, pp. 117-121
2013
-
Lung adenocarcinoma in the era of targeted therapies: Histological classification, sample prioritization, and predictive biomarkers
Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 503-508
-
The ALK translocation in advanced non-small-cell lung carcinomas: Preapproval testing experience at a single cancer centre
Histopathology, Vol. 62, Núm. 4, pp. 609-616
2012
-
A comparison of EGFR mutation testing methods in lung carcinoma: Direct sequencing, real-time PCR and immunohistochemistry
PLoS ONE, Vol. 7, Núm. 8
-
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
Journal of Clinical Pathology, Vol. 65, Núm. 8, pp. 751-757
2011
-
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma
Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 636-651
-
Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: A comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method
Histopathology, Vol. 59, Núm. 1, pp. 8-17
2010
-
A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model
Molecular Cancer Therapeutics, Vol. 9, Núm. 9, pp. 2582-2592
-
A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: A morphology-based approach in colorectal carcinoma
Journal of Molecular Diagnostics, Vol. 12, Núm. 3, pp. 292-299
-
The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung
PLoS ONE, Vol. 5, Núm. 8